Press release Oncology Venture signs agreement to out-license two pipeline assets as part of prioritized portfolio strategy

    NEXT STORY
    BioNTech to Raise USD 250 Million in Private Placement
    PREV STORY
    Burning Rock and CStone Pharmaceuticals reached a strategic collaboration on the co-development of companion diagnostics for pralsetinib in China
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Quanta Appoints Dr. Paul Komenda as New Chief Medical Officer

    author_avatar
    NASDAQ Market News

    Loxo Oncology to Announce Fourth Quarter and Year-End 2015 Financial Results  

    STAMFORD, Conn., March 08, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Immune Design Reports Third Quarter 2018 Financial Results and Provides Corporate Update

    Conference call at 1:30 pm Pacific today SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. ...

    author_avatar
    NASDAQ Market News